Johnson & Johnson receives FDA Approval for new lung cancer treatment
USA—Johnson & Johnson has received FDA approval for RYBREVANT® (amivantamab-vmjw) combined...
Read More
Tag: Johnson & Johnson
J&J invests US$850M in Proteologix acquisition to enhance dermatology portfolio
USA – Johnson & Johnson (J&J) has announced a definitive agreement to acquire...
Read More
PPB recalls Benylin Pediatric cough syrup due to safety concerns
KENYA—The Pharmacy and Poisons Board (PPB), Kenya’s drug regulator, has announced the recall of...
Read More
Johnson & Johnson sets sights on 20 drug launches amidst Stelara patent pressures
USA — Johnson & Johnson has set an ambitious goal, aiming to introduce a minimum of 20 new...
Read More
Johnson & Johnson MedTech invests US$400 million in cutting-edge device to address atrial fibrillation complications
USA – Johnson & Johnson MedTech has disclosed a substantial upfront investment of US$400...
Read More
Johnson & Johnson takes steps to make tuberculosis drug more accessible in Low- and Middle-Income Countries
USA — Johnson & Johnson (J&J) recently made a significant announcement, revealing its...
Read More
Johnson & Johnson faces investigation for allegedly overpricing critical tuberculosis drug in South Africa
SOUTH AFRICA —Pharmaceutical giant Johnson & Johnson (J&J), headquartered in the United...
Read More
South Africa’s COVID-19 vaccine contracts reveal disparities and risk assumptions
SOUTH AFRICA — An analysis of South Africa’s COVID-19 vaccine contracts has shed light on...
Read More
Neuromedicine startup Rapport Therapeutics secures US$150 million in Series B funding to propel clinical progress
USA — Rapport Therapeutics, a cutting-edge neuromedicine startup backed by Johnson & Johnson,...
Read More
Biosense Webster’s FDA approval paves the way for zero fluoroscopy workflow
USA —Biosense Webster, a distinguished entity within Johnson & Johnson MedTech has unveiled...
Read More
LATEST DIGITAL MAGAZINE
